|
Post by jefferson on Aug 11, 2014 8:53:32 GMT -5
I gotta admit, when I bought in to MNKD 2 something years ago, stuck with them through all the BS, that I didn't picture the day we announced a partner with killer terms to be trading at $9 and 2 bucks under the 52 week high from a few weeks back. Not going to pretend to be happy. I had always envisioned (conservatively I thought) that we would be $20+ on this news. Bummed. Now what? Wait a year or two for favorable sales? It's always something far away that is going to be the catalyst. The MM's hate this stock for whatever reason. It reminds me of what they did to AAPL the last couple years for no good reason.
I'm in the Caribbean. I'll be drinking painkillers all day. And night!
|
|
|
PPS
Aug 11, 2014 8:58:23 GMT -5
Post by nadathing on Aug 11, 2014 8:58:23 GMT -5
I put a sell order in for a few thousand shares at $15 before the open. Noe I'm hoping for a close above $10.00. I expected it would take 18-24 months for sales numbers to reflect a true value and buyout, but this is really disappointing.
|
|
|
Post by babaoriley on Aug 11, 2014 9:02:18 GMT -5
This price action is following a familiar pattern, as is the whole board reaction last night compared to this morning. But I'm pretty sure we are on a "get rich slow" path, not so bad. Lunch still costs money, you know.
|
|
|
PPS
Aug 11, 2014 9:03:57 GMT -5
Post by whosmitchconnor on Aug 11, 2014 9:03:57 GMT -5
Right there with you. I'm still in the green this time around having bought in the 5's, but I'm still slightly red overall taking a huge hit in Jan 2011. I can't say this is totally unexpected given how much this stock is manipulated, but you would have thought we might at least sniff pre-approval prices.
|
|
|
Post by ezrasfund on Aug 11, 2014 9:09:20 GMT -5
Reminds you of AAPL? What could be better than that? I am holding on to all my shares as the big risks are off the table. Need cash now? Instead of selling your shares why not lend them out and get 6% or more annual return paid monthly, as good as any dividend paying stock. One thing the shorts may not have counted on is that MNKD will not be issuing any more shares; they will be staying on the shelf. Matt and Al are trying to make good on their minimal dilution promise as best they can after wrestling with the FDA.
Sanofi was the partner all along, although others must have come in to try and outbid them. During all the trials and FDA submissions Sanofi's Lantus was the basal insulin used, so when MNKD said they were consulting with potential partners they were referring to Sanofi. And then there was the time Al said "Lantus is the best basal insulin."
The shorts will try to keep a lid on the price, and it may not spike, so it will be a slow and painful process of covering, but the floor on the share price keeps increasing.
|
|
|
PPS
Aug 11, 2014 9:53:34 GMT -5
Post by seanismorris on Aug 11, 2014 9:53:34 GMT -5
MNKD like Apple?
I doubled my money in Apple and got out.
I more than doubled my money in MNKD and I'm staying Long.
MNKD up less than 10% after the partner announcement? That's crazy considering a huge risk has been removed.
|
|
|
Post by mnholdem on Aug 11, 2014 9:54:56 GMT -5
You might want to wait few days before making any rash decisions.
|
|
|
PPS
Aug 11, 2014 10:36:51 GMT -5
Post by dreamboatcruise on Aug 11, 2014 10:36:51 GMT -5
I figured Aug 16 9 strike calls was a pretty safe bet. Guess not.
|
|
|
PPS
Aug 11, 2014 11:36:42 GMT -5
Chris-C likes this
Post by notamnkdmillionaire on Aug 11, 2014 11:36:42 GMT -5
All but one major obstacle are now removed. Unfortunately, MNKD is fairly valued at 3 billion dollars considering there won't be any revs for at least 9 months or so. The dilution has been disaterous for the stock. There could be other things that can move the PPS like license deals or upgrades etc. My theory is that once AFrezza starts to make in roads and diabetics use social media to praise the drug, we'll see the pps movement we have always wanted to see but haven't yet.
|
|
|
Post by kc on Aug 11, 2014 12:18:31 GMT -5
When the revenue starts rolling in Sanofi might want to buy the company assuming that the roll out goes well. This is a work in progress. The risk is off the table with FDA approval and Partnership. You can bet that when your get further approval from the EMA and other organizations that sales will happen.
They stated in the call that Sanofi distributes Diabetes Insulin to 120 countries. Think about the sales potential there once we get the proper approval. The risk has been removed for now.
|
|